Literature DB >> 3085890

Serum vitamin D metabolites are not related to growth rate, bone mineral content, or serum alkaline phosphatase in male puberty.

S Krabbe, C Christiansen, L Hummer.   

Abstract

Twenty boys were followed during their puberty for about 2 years with examinations every third month. At each examination we determined serum concentrations of 25OHD3, 1,25(OH)2D3, 24,25(OH)2D3, 25.26(OH)2D3, alkaline phosphatase (AP) and testosterone together with bone mineral content (BMC) at the distal forearm. Highly significant increases in both BMC (P less than 0.001), serum AP (P less than 0.001), and peak height velocity (PHV) followed the increase in serum testosterone. The boys were grouped according to time of maximal increase in BMC, AP, and PHV. The serum levels of the vitamin D metabolites were related to these points. No significant changes in any of the serum vitamin D metabolites were found. Thus vitamin D metabolism does not seem to be significantly influenced during the period of life when both the linear growth and bone mineralization is maximal.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3085890     DOI: 10.1007/bf02556871

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  17 in total

1.  Serum gonadotropin, testosterone and prolactin concentrations throughout puberty in boys: a longitudinal study.

Authors:  P A Lee; R B Jaffe; A R Midgley
Journal:  J Clin Endocrinol Metab       Date:  1974-10       Impact factor: 5.958

2.  Determination of mono- and dihydroxy-vitamin D metabolites in normal subjects and patients with different calcium metabolic diseases.

Authors:  L Hummer; B J Riis; C Christiansen; H Rickers
Journal:  Scand J Clin Lab Invest       Date:  1985-11       Impact factor: 1.713

3.  A selective and simplified radioimmunoassay of 25-hydroxyvitamin D3.

Authors:  L Hummer; L Nilas; L Tjellesen; C Christiansen
Journal:  Scand J Clin Lab Invest       Date:  1984-04       Impact factor: 1.713

Review 4.  Regulation of bone formation.

Authors:  L G Raisz; B E Kream
Journal:  N Engl J Med       Date:  1983-07-07       Impact factor: 91.245

5.  Longitudinal study of calcium metabolism in male puberty. I. Bone mineral content, and serum levels of alkaline phosphatase, phosphate and calcium.

Authors:  S Krabbe; C Christiansen
Journal:  Acta Paediatr Scand       Date:  1984-11

6.  Age-dependent variations in serum 1,25-dihydroxyvitamin D in childhood.

Authors:  B Lund; N Clausen; B Lund; E Andersen; O H Sørensen
Journal:  Acta Endocrinol (Copenh)       Date:  1980-07

7.  A sensitive and selective radioimmunoassay for serum 24,25-dihydroxycholecalciferol in man.

Authors:  L Hummer; C Christiansen
Journal:  Clin Endocrinol (Oxf)       Date:  1984-07       Impact factor: 3.478

8.  Plasma concentrations of vitamin D metabolites in puberty: effect of sexual maturation and implications for growth.

Authors:  L Aksnes; D Aarskog
Journal:  J Clin Endocrinol Metab       Date:  1982-07       Impact factor: 5.958

9.  A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies.

Authors:  T A Reinhardt; R L Horst; J W Orf; B W Hollis
Journal:  J Clin Endocrinol Metab       Date:  1984-01       Impact factor: 5.958

10.  Serum 1,25-dihydroxyvitamin D levels in normal children and in vitamin D disorders.

Authors:  R W Chesney; J F Rosen; A J Hamstra; H F DeLuca
Journal:  Am J Dis Child       Date:  1980-02
View more
  2 in total

1.  Serum vitamin D metabolites do not change in response to intravenous injection of thyrotropin releasing hormone (TRH) and growth hormone releasing factor (GHRF 1-44) in children.

Authors:  R Rosskamp; S Issa; W Burmeister
Journal:  J Endocrinol Invest       Date:  1988-01       Impact factor: 4.256

2.  Associations of vitamin D, parathyroid hormone and calcium with cardiovascular risk factors in US adolescents.

Authors:  Dylan M Williams; Abigail Fraser; Debbie A Lawlor
Journal:  Heart       Date:  2010-12-30       Impact factor: 5.994

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.